Sign in

CIK 0001231457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

GENELUX Corp

Sign in to watch
Ticker
GNLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 805-267-9889
Business address
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$155,693
in 6 filings

Net −$155,693. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-03 Cappello Joseph Chief Technical Officer Sale −668 $2.04 $1K 317,812
2026-08-31 Cappello Joseph Chief Technical Officer Sale −10,257 $2.74 $28K 318,480
2026-08-04 Cappello Joseph Chief Technical Officer Sale −653 $2.95 $2K 328,737
2026-06-16 Cappello Joseph Chief Technical Officer Grant or award +174,841 329,390
2026-05-11 Cappello Joseph Chief Technical Officer Sale −605 $2.97 $2K 154,549
2026-03-24 Cappello Joseph Chief Technical Officer Sale −906 $2.42 $2K 155,154
2025-11-17 Cappello Joseph Chief Technical Officer Sale −973 $5.37 $5K 156,060
2025-09-01 Cappello Joseph Chief Technical Officer Returned to the company · Stock Option (Right to Buy) −16,666 0
2025-09-01 Cappello Joseph Chief Technical Officer Grant or award · Stock Option (Right to Buy) +16,666 16,666
2025-09-01 Cappello Joseph Chief Technical Officer Returned to the company · Stock Option (Right to Buy) −80,000 0
2025-09-01 Cappello Joseph Chief Technical Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2025-09-01 Cappello Joseph Chief Technical Officer Returned to the company · Stock Option (Right to Buy) −13,333 0
2025-09-01 Cappello Joseph Chief Technical Officer Grant or award · Stock Option (Right to Buy) +13,333 13,333
2025-09-01 Cappello Joseph Chief Technical Officer Returned to the company · Stock Option (Right to Buy) −65,000 0
2025-09-01 Cappello Joseph Chief Technical Officer Grant or award · Stock Option (Right to Buy) +65,000 65,000
2025-08-27 Cappello Joseph Chief Technical Officer Grant or award +107,500 159,766
2025-08-27 Cappello Joseph Chief Technical Officer Grant or award · Stock Option (Right to Buy) +142,500 142,500
2025-08-21 Cappello Joseph Chief Technical Officer Sale −1,270 $3.33 $4K 158,496
2025-08-21 Cappello Joseph Chief Technical Officer Sale −1,463 $3.36 $5K 157,033
2025-05-12 Cappello Joseph VP, Pharmaceutical Development Sale −4,737 $2.92 $14K 52,266

Page 1 of 2 · 29 trades